Serum eosinophil cationic protein, myeloperoxidase, tryptase, eotaxin and Th2-L-like cytokines in Dermatitis herpetiformis.
BACKGROUND
Dermatitis herpetiformis (DH) is a subepidermal bullous disease characterized by a neutrophilic and eosinophilic infiltrate, together with activated lymphocytes that show preferential polarization towards the Th2-like phenotype. To date, the role of neither soluble mediators, such as cytokines, nor serum levels of myeloperoxidase (MPO), eosinophil cationic protein (ECP) and tryptase (TRY) have been studied in the peripheral blood of DH. In this study we investigated 40 DH subjects for possible alterations in MPO, ECP, TRY, eotaxin, interleukin (IL) 4 and IL-5 concentrations to evaluate the role of neutrophils, eosinophils and mast cells in the induction of skin lesions. Sera from 20 healthy subjects were tested as controls.


METHODS
Eotaxin, IL-4 and IL-5 serum contents were determined by a solid-phase enzyme-linked immunosorbent assay. A double antibody radioimmunoassay was used to measure serum levels of MPO, ECP and TRY.


RESULTS
Normal levels of eotaxin and IL-4 were found in all DH subjects; increased IL-5 levels were found only in 1 subject. The MPO levels were significantly higher in DH subjects than in healthy controls (p < 0.01). There was also a significant difference between the serum ECP levels of DH and healthy controls (p < 0.05). TRY was not revealed in the serum of DH subjects.


CONCLUSIONS
The determination of Th2-like cytokines and TRY serum levels is not important in quantifying the involvement of activated lymphocytes and mast cells in DH; however, the finding of high MPO and ECP serum levels seems to confirm that these products are good markers of the presence of activated neutrophils and eosinophils.
Caproni
Marzia
M
Department of Dermatological Sciences, University of Florence, Italy.
Cardinali
Carla
C
D'Agata
Alberino
A
Selvaggi
Walter
W
Fabbri
Paolo
P
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001798:Blood Proteins / Q000378:metabolism*; D054413:Chemokine CCL11; D018925:Chemokines / Q000097:blood*; D019742:Chemokines, CC / Q000097:blood; D002648:Child; D002675:Child, Preschool; D016207:Cytokines / Q000097:blood*; D003874:Dermatitis Herpetiformis / Q000097:blood* / Q000201:enzymology / Q000276:immunology; D047091:Eosinophil Granule Proteins; D005260:Female; D006801:Humans; D015847:Interleukin-4 / Q000097:blood; D015848:Interleukin-5 / Q000097:blood; D008297:Male; D008875:Middle Aged; D009195:Peroxidase / Q000097:blood; D012260:Ribonucleases; D012697:Serine Endopeptidases / Q000097:blood; D018418:Th2 Cells / Q000276:immunology / Q000378:metabolism; D053802:Tryptases
D001798:Blood Proteins; C515456:CCL11 protein, human; D054413:Chemokine CCL11; D018925:Chemokines; D019742:Chemokines, CC; D016207:Cytokines; D047091:Eosinophil Granule Proteins; D015848:Interleukin-5; D015847:Interleukin-4; D009195:Peroxidase; D012260:Ribonucleases; D012697:Serine Endopeptidases; D053802:Tryptases